Evofem earnings
WebApr 12, 2024 · Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York state that improves coverage for Phexxi® (lactic acid, citric acid and potassium bitartrate), its hormone-free ... WebMay 6, 2024 · NEW YORK, NY / ACCESSWIRE / May 6, 2024 / Evofem Biosciences, Inc. (NASDAQ:EVFM) will be discussing their earnings results in their 2024 First Quarter …
Evofem earnings
Did you know?
WebApr 10, 2024 · On April 5, 2024, Evofem Biosciences, Inc., a Delaware corporation (the "Company"), entered into a securities purchase agreement ("SPA"), with certain investors (the "Investors") providing for the ... WebMar 4, 2024 · The fourth quarter of 2024 was Evofem's first full quarter of product sales, following the U.S. commercial launch of Phexxi on September 8, 2024 as the first and only hormone-free, prescription ...
WebApr 12, 2024 · — Improves Phexxi coverage for more than 5.8 million New York lives — — Year-to-date, Evofem has gained Phexxi coverage for more than 22.1 million new lives — SAN DIEGO, April 12, 2024 ... WebAug 4, 2024 · Welcome to the Evofem Biosciences' Q2 conference call. If you haven't done so already, I encourage you to access the Q2 2024 presentation and the press release …
WebAug 4, 2024 · Evofem continues to expect net product sales in the range of $30 to $35 million for its 2024 fiscal year, representing 264% to 325% growth year-over-year. Gross … WebApr 10, 2024 · Get a real-time Evofem Biosciences, Inc. (EVFM) stock price quote with breaking news, financials, statistics, charts and more. ... Earnings Date: Mar 1, 2024: About EVFM. Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and …
WebGet the latest Evofem Biosciences Inc EVFM stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com. Top Stocks. Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. ... Evofem price target lowered to $2 from $30 at Piper Sandler Evofem price target lowered to $2 from $30 at Piper Sandler.
WebJan 9, 2024 · In Q2, Evofem Biosciences brought in $6.03 million in sales but lost $125.98 million in earnings. What Is ROCE? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital ... foods that irritate gumsWebApr 11, 2024 · Evofem Biosciences Stock Earnings Report Current P/E ratio: -0.0018 Price (Apr 11, 2024, EOD): $0.0208 (Find current average P/E ratios for all sectors below … electric fan oven with induction hobWeb19 hours ago · In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. ... Evofem Biosciences ... foods that irritate gallstonesWeb6 minutes ago · Evofem Biosciences, Inc., is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. electric fan oven with plugWebAbout Earnings Date. Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast … electric fan oven with grillWebApr 15, 2015 · It gives me great pleasure to confirm the offer for your full-time, exempt employment with Evofem, Inc. as Chief Medical Officer. You will report directly to Evofem’s CEO. This term of employment will begin on June 1, 2015 at 50% time and salary from June 1, 2015 to June 30, 2015 based on an annual salary of $250,000.00. You will be full-time ... foods that irritate hiatal herniaWebApr 6, 2024 · Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2024 Results - Earnings Call Transcript. SA Transcripts Wed, Aug. 11, 2024. foods that irritate hiatal hernia symptoms